ReviewAdvances in experimental medicine and biology2026
The Biological Role of Enveloped Virus Glycosylation and Its Interactions with Antiviral Lectins.
Review in Advances in experimental medicine and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Viral glycoproteins play an important role in the virus life cycle, especially for enveloped viruses, but they can also become targets for antiviral lectins. This chapter seeks to highlight how viruses exploit glycans for their benefit, including protein folding, protein stability, immune evasion, and glycan-lectin interactions in cell attachment and entry. Furthermore, this chapter discusses human endogenous lectins in the collectin and ficolin family that participate in innate immunity and antiviral defense through direct neutralization, opsonization, and activation of the complement cascade. Finally, this chapter brings up a few examples from a diverse group of xenogenous lectins that show potential as antiviral agents, with the ability to bind and neutralize enveloped viruses.
Indexed as
Identifiers
41917410What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.